Treatment of Genetic Diseases With CRISPR Genome Editing

Matthew J Kan^{1

2

3}, Jennifer A Doudna^{3

4

5

6

7}

Affiliations

¹ Division of Allergy, Immunology, and Bone Marrow Transplantation, Department of Pediatrics, University of California, San Francisco.
² Pediatric Scientist Development Program, Eunice Kennedy Shriver National Institute of Child Health and Human Development, San Francisco, California.
³ Innovative Genomics Institute, University of California, Berkeley.
⁴ Department of Molecular and Cell Biology, Department of Chemistry, and California Institute for Quantitative Biosciences (QB3), University of California, Berkeley.
⁵ Howard Hughes Medical Institute, University of California, Berkeley.
⁶ Molecular Biophysics & Integrated Bioimaging Division, Lawrence Berkeley National Laboratory, Berkeley, California.
⁷ Gladstone-UCSF Institute of Genomic Immunology, San Francisco, California.

Matthew J Kan et al. JAMA. 2022.

. 2022 Sep 13;328(10):980-981.

doi: 10.1001/jama.2022.13468.

Matthew J Kan^{1

2

3}, Jennifer A Doudna^{3

4

5

6

7}

¹ Division of Allergy, Immunology, and Bone Marrow Transplantation, Department of Pediatrics, University of California, San Francisco.
² Pediatric Scientist Development Program, Eunice Kennedy Shriver National Institute of Child Health and Human Development, San Francisco, California.
³ Innovative Genomics Institute, University of California, Berkeley.
⁴ Department of Molecular and Cell Biology, Department of Chemistry, and California Institute for Quantitative Biosciences (QB3), University of California, Berkeley.
⁵ Howard Hughes Medical Institute, University of California, Berkeley.
⁶ Molecular Biophysics & Integrated Bioimaging Division, Lawrence Berkeley National Laboratory, Berkeley, California.
⁷ Gladstone-UCSF Institute of Genomic Immunology, San Francisco, California.

No abstract available

MeSH terms